The
U.S. vaccine market is estimated to be worth USD 12.8 billion in 2012
and is further expected to reach USD 17.4 billion by 2018, growing at
a CAGR of 5.3% from 2012 to 2018. Human vaccine segment occupies
about 80% of the U.S. vaccine market.
Browse
the database at U.S. Vaccine Market - Industry Analysis, Size,
Share, Growth, And Forecast 2012 – 2018
http://www.transparencymarketresearch.com/us-vaccine-market.html
U.S.
will continue to lead the global vaccine market due to rising
prevalence of infectious diseases in humans and animals, and
advancement in biotechnology in the region. Short functional shelf
life of certain vaccines will have negative impact on the market
growth, but huge product pipeline of the multinational firms will
overcome this concern and will drive the future growth of the market.
Pediatric
vaccine segment in the U.S. human vaccine market enjoys high share as
well as high growth rate due to government compulsion for child
immunization. Adult & adolescent vaccine market is expected to
grow moderately over the next six years due to rising awareness and
increasing vaccination for human papillomavirus (HPV) and such other
viral diseases.
Livestock
vaccine is the leading segment of the overall U.S. animal vaccine
market accounting for 58.1% in 2012 due to more organized dairy
sector and increased awareness towards prevention of infectious
diseases in cattle. Bovine vaccine market is the largest revenue
generating segment of the overall Livestock vaccine market in 2012
due to rising vaccination to protect breeding animals against
infectious diseases. Together feline vaccine and canine vaccine
accounted for about 95.1% of the overall U.S. companion animal
vaccine market in 2011.
Request
for customization of this report :
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=553
In
2011, overall leading producers of human vaccine for the U.S. market
were Sanofi-Aventis, Merck, GlaxoSmithKline, Pfizer, Sanofi-Pasture
and Novartis. The leading producers of animal vaccine for the U.S.
market includes Pfizer Animal Health, Merial (Sanofi-Aventis),
Intervet/Schering-Plough (Merck) and Novartis Animal Health.
This
report helps to identify factors, which will be the driving force
behind the U.S. Vaccine market and sub-markets in the next six years.
The report provides extensive analysis of the U.S. vaccine market,
current market trends, industry drivers and challenges for better
understanding of the U.S. vaccine market structure. The report has
segregated the U.S. vaccine industry in terms of its product type.
Annual estimates and forecasts are provided for the period 2012
through 2018 in terms of value in USD million.
Segments Analyzed
Browse
all Press Releases:
http://www.transparencymarketresearch.com/press-releases.htm
U.S.
vaccine market- by Product
Human vaccine
Pediatric Vaccines
Adult & Adolescent vaccine
Other human vaccine
Browse
all Article : http://www.transparencymarketresearch.com/articles.htm
Animal vaccine
Livestock vaccine
Bovine vaccine
Porcine vaccine
Ovine vaccine
Companion animal vaccine
Feline vaccine
Canine vaccine
Equine vaccine
Other animal vaccine
About
Us
Transparency
Market Research is a global market intelligence company, providing
global business information reports and services. Our exclusive blend
of quantitative forecasting and trends analysis provides
forward-looking insight for thousands of decision makers. We are
privileged with highly experienced team of Analysts, Researchers, and
Consultants, who use proprietary data sources and various tools and
techniques to gather, and analyze information.
Our
data repository is continuously updated and revised by a team of
research experts, so that it always reflects the latest trends and
information. With a broad research and analysis capability,
Transparency Market Research employs rigorous primary and secondary
research techniques in developing distinctive data sets and research
material for business reports.
Contact
Sheela
AK
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-618-1030
USA
- Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
No comments:
Post a Comment